Ernst, T., Chase, A., Score, J., Hidalgo-Curtis, C., Bryant, C., Jones, A., Waghorn, K., Zoi, K., Ross, F., Reiter, A., Hochhaus, A., Drexler, H., Duncombe, A., Cervantes, F., Oscier, D., Boultwood, J., Grand, F., & Cross, N. (2016). INACTIVATING MUTATIONS OF THE HISTONE METHYLTRANSFERASE EZH2 ARE ASSOCIATED WITH CHROMOSOME 7 ABNORMALITIES IN MYELOID DISORDERS. 95, 233–233.

Ernst, T., et al. INACTIVATING MUTATIONS OF THE HISTONE METHYLTRANSFERASE EZH2 ARE ASSOCIATED WITH CHROMOSOME 7 ABNORMALITIES IN MYELOID DISORDERS. 2016, pp. 233–33.

Ernst, T, A Chase, J Score, C Hidalgo-Curtis, C Bryant, A Jones, K Waghorn, et al. 2016. “INACTIVATING MUTATIONS OF THE HISTONE METHYLTRANSFERASE EZH2 ARE ASSOCIATED WITH CHROMOSOME 7 ABNORMALITIES IN MYELOID DISORDERS.” In , 95:233–33.